Select Page

Annual Conference

Speakers

Conference Opening

Karin Sartorius

Canton Basel-Stadt

Panel

Bernard Spörri

Swissmedic

Thinh Nguyen

US FDA

Mike Wallenstein

Novartis

Sebastian Fuchs

Swissmedic

John Weiner

US FDA

Sabina Hoekstra

Team-NB

Session 1

Marie Dutarte

Executive Director | EUPATI

Maria Dutarte is the Executive Director of the European Patients’ Academy (EUPATI) since 2020. Maria has previously worked for the European AIDS Treatment Group (EATG) coordinating patient involvement in a number of training initiatives and scientific projects. She has also worked for different scientific and international organisations, e.g. French National Research Center for Scientific Research (CNRS), International AIDS Society (IAS), The Global Fund to Fight AIDS, Tuberculosis and Malaria and The International Foundation for Science (IFS). Her educational background is in International Education and Communications.

Rahel von Rohr

Senior Consultant | anteris helvetia

Rahel von Rohr is a PMP certified project manager with a biomedical engineering degree from ETH Zurich and a strong track record in the medical device and combined product market. In her current position as Senior Consultant at anteris helvetia AG she supports companies in developing and marketing drug device combination products and leads projects from ideation to design transfer, both with small start-ups and global big pharma.

Stephan Affolter

Ypsomed

This Bio is currently under revision and will be uploaded shortly. We thank you very much for your patience.

Session 2

Paolo Decuzzi

Senior Scientist and Professor of Biomedical Engineering | Italian Institute of Technology

Dr. Paolo Decuzzi is a Senior Scientist and Professor of Biomedical Engineering at the Italian Institute of Technology (IIT) in Genoa – Italy where, in July 2015, he founded the Laboratory of Nanotechnology for Precision Medicine returning in Europe after 10 years of activities conducted in different Clinical Research Institutions in Houston, Texas – USA. Decuzzi is a board member of multiple scientific associations, institutions, and advisory panels, including the Controlled Release Society, IIT, ERC, and the biotech accelerator program SPARK at Stanford. His multidisciplinary research focuses on the rational design of nanoconstructs and implantable devices for the treatment and imaging of various diseases and the development of AI-based models for optimizing the therapeutic efficacy of drug delivery systems. In this context, Decuzzi has published 200+ scientific contributions and generated 10+ patents. His activities have been funded by multiple organizations, in the US and EU, and private companies totaling over $15 million.

San Pun

TBC | TBC

San Pun, Ph.D. has broad experiences in life sciences, including in different areas of pharmaceutical, clinical and diagnostic industries. He is both an author with top notch publications and an inventor. Recently, he is founding a high-tech startup aiming to provide a personalized medical system in the treatment of thrombosis.

Laura Fregonese

European Medicines Agency

This Bio is currently under revision and will be uploaded shortly. We thank you very much for your patience.

Claudia Dollins

BMS

This Bio is currently under revision and will be uploaded shortly. We thank you very much for your patience.

Session 3

Frederik Flöther

Quantum Industry Consultant & Computational Scientist – Life Sciences & Healthcare | IBM

Dr. Frederik Flöther is an IBM Quantum Industry Consultant and Computational Scientist for the healthcare and life sciences industries. With over 10 years of experience in quantum computing and artificial intelligence (AI), Frederik leads consulting and research engagements to create value for clients with these technologies. He was elected to the IBM Academy of Technology and is a Master Inventor and Qiskit Advocate. Frederik holds a PhD in physics, with a focus on photonic quantum computing, and a MA, MSci, and BA from the University of Cambridge as well as a professional certificate in quantum computing applications from MIT. In total, he has authored over 30 filed patents, peer-reviewed publications, and white papers.

Iain Simpson

Director, Front-End Innovation | Phillips Medisize

Iain is a Commercial Director at Phillips-Medisize, where he is part of a global team developing industry leading solutions and platforms for drug delivery, digital medicine and connected health. He has more than 30-years’ experience in multi-disciplinary technology and product development; the last 20 years have in healthcare and increasingly focused on the use of devices and digital technologies to create product differentiation, improve patient engagement and better measure clinical outcomes in real world settings. He has a degree and PhD in physics both from University College London and an MBE in Technology Management from the Open University. He has published and presented at conferences on drug delivery, digital biomarkers, healthcare technology and technology licensing. He is an associate lecturer at the University of Cambridge in Bioscience Enterprise.

Lada Leyens

Global Regulatory Lead, Clinical Trial Innovation | Roche

Lada Leyens has a background in human genetics, health economics and personalised medicine. She has worked at Health Authorities for over 8 years, mainly as a clinical trial assessor and GCP inspector at Swissmedic. At EMA she was in the specialised disciplines office working in the centralised procedure on clinical pharmacology and pharmacogenomics aspects. Lada joined Roche in 2019, where she works as Global Regulatory Lead on Clinical Trial Innovation and digital health programs. In this role she is working to increase the adoption of innovative methods in Roche’s drug development programs and to increase their acceptance externally. Lada represents Roche in the Clinical Research Expert Group at EFPIA, including its Innovative Clinical Trial pillar.

Antoine Bourrier

Capgemini

This Bio is currently under revision and will be uploaded shortly. We thank you very much for your patience.